⌘K

Login Start Free

Home/Filings/4/0001213900-16-017291

4//SEC Filing

DelMar Pharmaceuticals, Inc. 4

Accession 0001213900-16-017291

$HURACIK 0001498382operating

View on SEC.gov Company Profile

Filed

Oct 4, 8:00 PM ET

Accepted

Oct 5, 10:20 AM ET

Size

4.7 KB

Accession

0001213900-16-017291

Insider Transaction Report

Form 4

Period: 2016-10-03

DelMar Pharmaceuticals, Inc.DMPI

Director

Transactions

Other
Common Stock
2016-10-03$3.20/sh+528$1,690→ 887 total

Footnotes (1)

[F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.

Documents

1 file

4
f4100316mohr_delmarpharm.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

DelMar Pharmaceuticals, Inc.

CIK 0001498382

Entity typeoperating

IncorporatedNV

Related Parties

1

filerCIK 0001498382

Filing Metadata

Form type: 4
Filed: Oct 4, 8:00 PM ET
Accepted: Oct 5, 10:20 AM ET
Size: 4.7 KB

View on SEC.gov